Roadshow
Exosome
Our commercialized h-MSCs exosomes. ExoCake and EXOVIA have been approved by PCPC and received INCI (35046), featuring the highest isolation and purification technology that surpasses industry standards providing high quality with promising outcomes for better, healthy, and dewy skin.
Join us at BIO 2024, June 3-6 in San Diego, where BIONET Corp. will be showcasing our cutting-edge solutions and services. We can't wait to connect with you to discuss how we're shaping the future of biotechnology. Find us at Booth 1917. See you there! #BIO2024#TAIWAN PAVILION
A New Favorite in Aesthetics: BIONET’s Exosomes
BIONET's exosomes are not limited to professional skin rejuvenation solutions; we are also pioneer in exosome technology.
With 25 years of experience in regenerative medicine, BIONET's exosomes are produced using exclusive nano-purification technology.
Our rapid and stable production techniques enable large-scale production of exosomes with high purity and quality standards.
BIONET has developed exosomes sourced from diverse cell components, including amniotic fluid, umbilical cord blood, and umbilical cord. Furthermore, we are the first company to obtain approval for INCI Names for mesenchymal stem cell exosomes.
Experience youthful and healthier skin with BIONET, embracing age reversal vitality from these remarkable advancements.
.jpg)
- #ExoCake
- #EXOVIA
- #Exosome
- #Bionet cell therapy
- #Bionet pet exosome
- #Bionet pet cell therapy
- #Bionet Taiwan
- #Bionet stem cell banking
- #Bionet Corp.
- #Bionet therapeutic
- Established 1999
- Company BIONET Corp.
- Telephone +886-2-2795-1777 #1517
- Email AmeliaYang@GGA.ASIA
- Address No.28, Ln.36, Xinhu 1st Rd., Neihu Dist., Taipei City 114065, Taiwan
Established in 1999, the BIONET Group has become a pioneering force in cell therapy, precision health, and digital healthcare through cross-border technologies. Comprising BIONET Corp., GGA, and BIONET Therapeutics, our focus on regenerative medicine and advanced products like exosome, stem cells, and genetic testing has benefited over 1.6 million people across 17 countries.
Our commercialized h-MSCs exosomes. ExoCake and EXOVIA have been approved by PCPC and received INCI(35046), featuring the highest isolation and purification
technology that surpasses industry standards providing high quality with promising outcomes for better, healthy,and dewy skin.